Clinical trial
An Open-label Uncontrolled Single Centre Investigation for the Evaluation of the Safety and Performance Characteristics of the Dermal Filler of Mesoestetic Mesofiller Mesotox for the Correction of Wrinkles and Rehydration of the Face. Clinical Investigation to Assess Safety and Performance of Mesofiller Mesotox.
NCT06477432 is registered in ClinicalTrials.gov with Mesoestetic Pharma Group S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Uncontrolled Single Centre Investigation for the Evaluation of the Safety and Performance Characteristics of the Dermal Filler of Mesoestetic Mesofiller Mesotox for the Correction of Wrinkles and Rehydration of the Face. Clinical Investigation to Assess Safety and Performance of Mesofiller Mesotox.
- Lead sponsor
- Mesoestetic Pharma Group S.L.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 15, 2022
- Completion date
- July 5, 2023
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin aging, skin wrinkling